Market Tracker

05/30 4:45pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.4144
Delayed Data
As of May 27
 +0.0044 / +1.07%
Today’s Change
0.29
Today|||52-Week Range
1.50
-64.58%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.41
Today’s open0.41
Day’s range0.41 - 0.42
Volume505,046
Average volume (3 months)1,535,739
Market cap$96.9M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)+13.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.21-2.82%
CLCDCoLucid Pharmaceutic...+0.07+1.12%
CRMECardiome Pharma Corp+0.08+1.69%
OHRPOHR Pharmaceutical I...+0.03+0.97%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 11, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts